PGx Semaglutide Test

Understand the genetic, metabolic, and clinical factors that influence semaglutide treatment outcome.

Connect with our experts

To Book a test

call : +91 75691 32891

What is Semaglutide Pharmacogenomics Test

The Semaglutide PGx Test evaluates clinically relevant genetic variants in genes involved in GLP-1 receptor signalling and metabolic regulation. These genetic insights help clinicians understand potential variability in treatment efficacy and tolerability, supporting personalised treatment decisions, outcome optimisation, and improved patient management.

Who can take this test?

  1. 1. Initiating Semaglutide Therapy :  Support personalised treatment planning by understanding genetic factors that may influence response to semaglutide.
  2. 2. Suboptimal Response to Semaglutide :  Identify genetic factors that may contribute to reduced treatment effectiveness despite appropriate therapy.
  3. 3. Strong Family History of Type 2 Diabetes or Obesity :  Gain insights into inherited genetic risks associated with obesity and metabolic disease.
  4. 4. Individuals Concerned About Drug Related Side Effects :  Understand genetic factors that may influence individual variability in treatment tolerability.
  5. 5. Complex or Resistant Metabolic Disease : Uncover underlying genetic contributors that may impact metabolic health and treatment outcomes.

How does it work?

  • 1. Sample Collection - Submit a saliva sample using a simple, non-invasive collection process.
  • 2. Advance PGx Testing - Clinically relevant genes influencing semaglutide response are analysed.
  • 3. Response Prediction - Genetic and metabolic markers are evaluated to predict treatment effectiveness.
  • 4. Personalised Report - Receive detailed insights on efficacy, tolerability, and expected outcomes.
  • 5. Clinical Decision Support - Apply the results to optimise therapy and improve patient management.

Comprehensive Test Overview

  1. 1. Pharmacogenomics analysis 
  2. 2. Pharmacokinetics 
  3. 3. Pharmacodynamics 
  4. 4. Lifestyle and Environmental Modifiers 
  5. 5. Safety Profile and Comorbidity Index 

Test Specification

Technique

Allele specific PCR for precise variant detection

Platform

Multiplex PCR assay for simultaneous analysis

Sample Type

Non-invasive saliva sample collection and testing

TAT

Comprehensive results delivered within 10 days

Connect with our expert

Why choose OneDNA

Comprehensive Coverage

Comprehensive testing across both molecular and cytogenetic platforms

Accredited Laboratories

NABL & CAP accredited lab

Support & Care

End-to-end support including genetic counselling and report guidance.

Early & Accurate

High accuracy with advanced technologies and stringent quality controls

Get our brochure

Download our brochure to learn more about Semaglutide PGx Test

Download now

Frequently Asked Questions

The test provides genetic insights that may help estimate the likelihood of treatment effectiveness and variability in response. However, clinical outcomes are also influenced by factors such as lifestyle, adherence, dosing, and overall health.

The test evaluates genetic factors that may influence individual differences in treatment tolerability and safety, helping clinicians make more informed therapeutic decisions.

Testing requirements may vary by region and healthcare provider. Please consult your healthcare professional or contact the laboratory for specific guidance.

Yes. All genetic data and personal information are handled according to applicable privacy, confidentiality, and data protection standards.

Yes. Individuals who are not achieving expected clinical outcomes may benefit from understanding whether genetic factors could be influencing treatment response.

Some Blogs from us

Our Companies

Screens for 90+ conditions

Get in touch

Have questions or need assistance? Get in touch with our team—we’re here to help.

Fill out the form below to get instant access to the product brochure.